BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11156703)

  • 1. Genetic basis of primary hyperoxaluria type II.
    Webster KE; Cramer SD
    Mol Urol; 2000; 4(4):355-64. PubMed ID: 11156703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2.
    Cregeen DP; Williams EL; Hulton S; Rumsby G
    Hum Mutat; 2003 Dec; 22(6):497. PubMed ID: 14635115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II.
    Cramer SD; Ferree PM; Lin K; Milliner DS; Holmes RP
    Hum Mol Genet; 1999 Oct; 8(11):2063-9. PubMed ID: 10484776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late diagnosis of primary hyperoxaluria type 2 in the adult: effect of a novel mutation in GRHPR gene on enzymatic activity and molecular modeling.
    Levin-Iaina N; Dinour D; Romero L; Ron R; Brady RL; Cramer SD; Holtzman EJ
    J Urol; 2009 May; 181(5):2146-51. PubMed ID: 19296982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe child form of primary hyperoxaluria type 2 - a case report revealing consequence of GRHPR deficiency on metabolism.
    Konkoľová J; Chandoga J; Kováčik J; Repiský M; Kramarová V; Paučinová I; Böhmer D
    BMC Med Genet; 2017 May; 18(1):59. PubMed ID: 28569194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hyperoxaluria type 2 in children.
    Johnson SA; Rumsby G; Cregeen D; Hulton SA
    Pediatr Nephrol; 2002 Aug; 17(8):597-601. PubMed ID: 12185464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of substrate specificity in human glyoxylate reductase/hydroxypyruvate reductase.
    Booth MP; Conners R; Rumsby G; Brady RL
    J Mol Biol; 2006 Jun; 360(1):178-89. PubMed ID: 16756993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutation in the GRHPR gene in a Chinese patient with primary hyperoxaluria type 2 requiring renal transplantation from a living related donor.
    Lam CW; Yuen YP; Lai CK; Tong SF; Lau LK; Tong KL; Chan YW
    Am J Kidney Dis; 2001 Dec; 38(6):1307-10. PubMed ID: 11728965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and genetic diagnosis of the primary hyperoxalurias: a review.
    Rumsby G
    Mol Urol; 2000; 4(4):349-54. PubMed ID: 11156702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2.
    Knight J; Holmes RP; Milliner DS; Monico CG; Cramer SD
    Nephrol Dial Transplant; 2006 Aug; 21(8):2292-5. PubMed ID: 16597637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hyperoxaluria type 2: enzymology.
    Giafi CF; Rumsby G
    J Nephrol; 1998; 11 Suppl 1():29-31. PubMed ID: 9604806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in our understanding of primary hyperoxaluria type 2.
    Cregeen DP; Rumsby G
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S348-50. PubMed ID: 10541261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary hyperoxaluria in Coton de Tulear.
    Vidgren G; Vainio-Siukola K; Honkasalo S; Dillard K; Anttila M; Vauhkonen H
    Anim Genet; 2012 Jun; 43(3):356-61. PubMed ID: 22486513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.
    Buchalski B; Wood KD; Challa A; Fargue S; Holmes RP; Lowther WT; Knight J
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165633. PubMed ID: 31821850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary hyperoxaluria].
    De Pauw L; Toussaint C
    Rev Med Brux; 1996 Apr; 17(2):67-74. PubMed ID: 8685551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of primary hyperoxaluria type 2 (L-glyceric aciduria) in patients with maintained renal function or end-stage renal failure.
    Marangella M; Petrarulo M; Cosseddu D; Vitale C; Cadario A; Barbos MP; Gurioli L; Linari F
    Nephrol Dial Transplant; 1995; 10(8):1381-5. PubMed ID: 8538930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
    van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR
    Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular aetiology of primary hyperoxaluria and its implications for clinical management.
    Danpure CJ; Rumsby G
    Expert Rev Mol Med; 2004 Jan; 6(1):1-16. PubMed ID: 14987413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of liver and kidney proteins in a mouse model for primary hyperoxaluria type I.
    Hernández-Fernaud JR; Salido E
    FEBS J; 2010 Nov; 277(22):4766-74. PubMed ID: 20977670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and expression of a cDNA for human hydroxypyruvate/glyoxylate reductase.
    Rumsby G; Cregeen DP
    Biochim Biophys Acta; 1999 Sep; 1446(3):383-8. PubMed ID: 10524214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.